HMG 75iu Driada Medical

HMG 75iu

Human menopausal gonadotropin (hMG) is a medication used to treat fertility disorders in both men and women. It is a mixture of two gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

Action mechanism

When injected, hMG is absorbed into the body through muscle tissue. It stimulates testosterone production and has become popular in anti-aging clinics and biotech companies.

hMG differs from hCG in its binding properties. While hCG binds primarily to LH receptors, hMG naturally binds to both LH and FSH receptors. hMG promotes sperm maturation and differentiation, as well as increasing testicular size, libido, and mood. It is important for maintaining testicular activity and preventing atrophy.

hMG is excreted primarily through the kidneys, and its pharmacokinetics in patients with renal or hepatic impairment have not been extensively studied.

Purpose of use

hMG was initially developed to treat female infertility, but is also used in hormone replacement therapy for men. In bodybuilding, hMG is commonly used in post-cycle therapy (PCT) to support testicular function and fertility. The combination of hCG and hMG has shown improved recovery after steroid cycles.

How to use

Treatment with hMG should be initiated under the supervision of a physician experienced in fertility treatments. The dosage and duration of treatment will vary depending on individual response. hMG can be used alone or in combination with a GnRH agonist or antagonist, depending on the treatment protocol.

To preserve testicular activity during steroid cycles longer than 10 weeks, it is recommended to begin using hMG in the first week to prevent atrophy. The typical protocol involves hMG injections at a dose of 75-150 IU two to three times a week, along with hCG injections at a dose of 250-500 IU two to three times a week. Hypogonadotropic hypogonadism may require a dose of 5-10 IU daily for several months.

Athletes seeking performance enhancement can take up to 10 IU per day, with an additional 5 IU dose 30 minutes before training on training days.

In cases of severe azoospermia induced by anabolic steroids, a protocol of biweekly injections of 10,000 IU of hCG and daily injections of 75 IU of hMG has been used for 3 months. Care must be taken to avoid overstimulation of the Leydig cells.

How to prepare a solution

To prepare the solution for injection, draw a diluent into a syringe and inject it into the vial containing the lyophilized powder. Tilt the vial so that the needle touches the wall of the vial, allowing the diluent to gradually flow. Gently mix the solution without shaking or shaking the vial until the lyophilized powder dissolves completely, resulting in a clear liquid. Avoid mixing different peptides in the same syringe.

Administration

• The injection can be administered subcutaneously or intramuscularly, depending on personal preference.

Effects

• Increased endogenous testosterone levels
• Increased sperm production
• Improved libido and mood
• Restoring fertility
• Preservation of testicular activity during steroid cycles
• Possibility of restoring natural testosterone production and fertility after steroid abuse

Side effects

• Abdominal pain
• Shortness of breath
• Breast swelling
• Sensitive breasts
• Nausea
• Weight gain
• Swelling of the hands and feet
• Mild skin rash
• Pain in the testicles

Drug profile

• Half-life: LH (13.8-1020 minutes) and FSH (21.3-1090 minutes)
• Frequency of intake: Once every 3 days

Contraindications

• Hypersensitivity to menotropin or to any of the excipients of the drug
• Women with tumors of the pituitary gland or hypothalamus, ovarian, uterine, or breast cancer, gynecological bleeding of unknown cause, or ovarian cysts or enlarged ovaries not due to polycystic ovary disease
• The outcome of treatment is unlikely to be favorable in cases of primary ovarian insufficiency, malformations of the sexual organs incompatible with pregnancy or uterine fibroids incompatible with pregnancy.
• Use during pregnancy or breastfeeding is contraindicated.

Injections

1. Use an insulin syringe for subcutaneous or intramuscular injections.
2. Disinfect the rubber stopper of the vial and the injection site with alcohol.
3. Slowly draw the medicine into the syringe and inject it slowly.

Conservation

• Keep the medicine away from light.
• Keep refrigerated at 2-8°C.
• Do not freeze.
• After reconstitution, the solution can be stored for up to 28 days at a temperature not exceeding 25°C.
• After dissolution in the included solvent, the solution should be administered immediately.
• Keep out of reach of children and do not use after the expiry date.